← Leaderboards
Jeffrey E Segall
Yeshiva University
$5,984,539
Attributed
$5,984,539
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $680.8K · FY2005–17$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,984,539 · 7
By mechanism
R01$2,952,790 · 1
P01$2,242,008 · 2
R21$774,650 · 2
R13$13,000 · 1
P41$2,091 · 1
Top collaborators
No co-investigators on record.
Most similar at Yeshiva University
Same institution · by research overlap
- E Richard Stanley$18,857,508
- Dennis William Dickson$25,196,666
- Jeffrey W. Pollard$21,159,692
- Cedric S Raine$8,136,908
- Charles K Abrams$3,528,369
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsNeoplastic CellIn VivoIn VitroNeoplasm MetastasisEvaluationTumorChemotaxisCell MotilitySignal TransductionBreast Cancer CellMeasurementLigandsEpidermal Growth Factor ReceptorEgf GeneProteinsMalignant NeoplasmsGrowthProgramsFamily MemberImagePrimary NeoplasmTumor GrowthMacrophage
Grant awards (26)
ErbB and Intravsation During Metastasis$274,221
P01 · FY2017 · CA · contact PI
ErbB and Intravsation During Metastasis$274,221
P01 · FY2016 · CA · contact PI
ErbB and Intravsation During Metastasis$274,221
P01 · FY2015 · CA · contact PI
The role of KIF9 in glioma invasion$208,750
R21 · FY2015 · NS · contact PI
ErbB and Intravsation During Metastasis$274,221
P01 · FY2014 · CA · contact PI
The role of KIF9 in glioma invasion$250,500
R21 · FY2014 · NS · contact PI
ErbB1 and ErbB2 Roles in Invasion and Intravasation$226,378
P01 · FY2012 · CA · contact PI
ERBB1 AND ERBB2 IN TUMOR MOTILITY AND METASTASIS$283,878
R01 · FY2011 · CA · contact PI
ErbB1 and ErbB2 Roles in Invasion and Intravasation$234,432
P01 · FY2011 · CA · contact PI
ERBB1 AND ERBB2 IN TUMOR MOTILITY AND METASTASIS$292,658
R01 · FY2010 · CA · contact PI
ErbB1 and ErbB2 Roles in Invasion and Intravasation$233,379
P01 · FY2010 · CA · contact PI
ERBB1 AND ERBB2 IN TUMOR MOTILITY AND METASTASIS$292,658
R01 · FY2009 · CA · contact PI
ErbB1 and ErbB2 Roles in Invasion and Intravasation$228,799
P01 · FY2009 · CA · contact PI
ERBB1 AND ERBB2 IN TUMOR MOTILITY AND METASTASIS$292,658
R01 · FY2008 · CA · contact PI
ErbB1 and ErbB2 Roles in Invasion and Intravasation$222,136
P01 · FY2008 · CA · contact PI
Development of An In vivo Metastasis Screen$166,000
R21 · FY2008 · CA · contact PI
ERBB1 AND ERBB2 IN TUMOR MOTILITY AND METASTASIS$285,388
R01 · FY2007 · CA · contact PI
Development of An In vivo Metastasis Screen$149,400
R21 · FY2007 · CA · contact PI
2007 Gradient Sensing & Directed Cell Migration GRC$13,000
R13 · FY2007 · GM · contact PI
VISUALIZATION OF FLOURESENCE DATA USING PSC'S VOLUME BROWSER$1,028
P41 · FY2005 · RR
ERBB1 AND ERBB2 IN TUMOR MOTILITY AND METASTASIS$300,600
R01 · FY2004 · CA
Visualization of Flouresence data using PSC's Volume Browser$1,063
P41 · FY2004 · RR
ERBB1 AND ERBB2 IN TUMOR MOTILITY AND METASTASIS$300,600
R01 · FY2003 · CA
ERBB1 AND ERBB2 IN TUMOR MOTILITY AND METASTASIS$300,975
R01 · FY2002 · CA
ERBB1 AND ERBB2 IN TUMOR MOTILITY AND METASTASIS$301,500
R01 · FY2001 · CA
ERBB1 AND ERBB2 IN TUMOR MOTILITY AND METASTASIS$301,875
R01 · FY2000 · CA